X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cerivastatin (442) 442
humans (274) 274
pharmacology & pharmacy (201) 201
male (163) 163
statins (136) 136
female (117) 117
pravastatin (110) 110
animals (105) 105
simvastatin (103) 103
index medicus (95) 95
middle aged (84) 84
atorvastatin (83) 83
drug interactions (83) 83
rhabdomyolysis (83) 83
cholesterol (74) 74
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (74) 74
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (72) 72
adult (69) 69
gemfibrozil (67) 67
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (62) 62
aged (61) 61
cardiac & cardiovascular systems (61) 61
lovastatin (61) 61
pharmacokinetics (58) 58
hypercholesterolemia (51) 51
in-vitro (51) 51
metabolism (51) 51
dose-response relationship, drug (50) 50
rats (49) 49
coa reductase inhibitors (48) 48
pharmacology/toxicology (46) 46
pyridines - pharmacology (46) 46
medicine & public health (44) 44
statin (44) 44
rhabdomyolysis, drug-induced (42) 42
hmg-coa reductase (39) 39
drug-interactions (38) 38
myopathy (38) 38
safety (38) 38
fluvastatin (37) 37
pyridines - therapeutic use (37) 37
atherosclerosis (36) 36
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (35) 35
atorvastatin calcium (34) 34
hydroxymethylglutaryl-coa reductase inhibitors - pharmacokinetics (34) 34
cells, cultured (33) 33
efficacy (33) 33
pyridines - adverse effects (33) 33
risk (32) 32
risk factors (32) 32
plasma-concentrations (31) 31
toxicology (31) 31
anticholesteremic agents - therapeutic use (30) 30
coa reductase inhibitor (30) 30
expression (30) 30
inhibition (30) 30
prevention (30) 30
therapy (30) 30
coenzyme-a reductase (29) 29
hypercholesterolemia - drug therapy (29) 29
time factors (28) 28
cerivastatin, adverse reactions (27) 27
hmg-coa reductase inhibitor (27) 27
mice (27) 27
treatment outcome (26) 26
medicine, general & internal (25) 25
muscular diseases - chemically induced (25) 25
pyridines - pharmacokinetics (25) 25
rhabdomyolysis - chemically induced (25) 25
area under curve (24) 24
cross-over studies (24) 24
elderly (24) 24
administration, oral (23) 23
drug safety and pharmacovigilance (23) 23
medicine, research & experimental (23) 23
coronary-heart-disease (22) 22
analysis (21) 21
biochemistry & molecular biology (21) 21
cholesterol - blood (21) 21
cholesterol, ldl - blood (21) 21
disease (21) 21
hmg-coa reductase inhibitors (21) 21
men (21) 21
nitric-oxide synthase (21) 21
gemfibrozil - pharmacology (20) 20
heptanoic acids - pharmacology (20) 20
hyperlipidemias - drug therapy (20) 20
lipids (20) 20
pharmacology (20) 20
pyridines - administration & dosage (20) 20
drug therapy, combination (19) 19
endothelium, vascular - drug effects (19) 19
hepatic-uptake (19) 19
peripheral vascular disease (19) 19
pyrroles - pharmacology (19) 19
simvastatin - pharmacology (19) 19
apoptosis (18) 18
cerivastatin, adverse reactions - serious (18) 18
drug therapy (18) 18
endocrinology & metabolism (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (506) 506
French (12) 12
Japanese (7) 7
Spanish (6) 6
German (5) 5
Korean (4) 4
Russian (3) 3
Italian (2) 2
Chinese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 03/2018, Volume 115, Issue 13, pp. 3196 - 3199
Journal Article
AMERICAN JOURNAL OF CARDIOLOGY, ISSN 0002-9149, 01/2005, Volume 95, Issue 1, pp. 120 - 122
There is an increasing trend among physicians to use 3-hydroxy-3-methylglutaryl, coenzyme A reductase inhibitors (statins) in combination with other... 
CARDIAC & CARDIOVASCULAR SYSTEMS | REPAGLINIDE | METABOLISM | PHARMACOKINETICS | PLASMA-CONCENTRATIONS | INCREASES | CERIVASTATIN | ROSIGLITAZONE | DYSLIPIDEMIA | COMBINATION | ROSUVASTATIN
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 06/2012, Volume 33, Issue 11, pp. 1397 - 1407
Statins protect against cardiovascular-related mortality but induce skeletal muscle toxicity. To investigate mechanisms of statins, we tested the hypothesis... 
Heart | CARDIAC & CARDIOVASCULAR SYSTEMS | Mitohormesis | PGC-1-ALPHA | TOXICITY | Statin | Mitochondrial biogenesis | BIOGENESIS | ROS | TRANSCRIPTIONAL CONTROL | CERIVASTATIN | RADICALS | ENERGY-METABOLISM | SIMVASTATIN | EXPRESSION
Journal Article
Drug Discovery Today, ISSN 1359-6446, 01/2019, Volume 24, Issue 1, pp. 9 - 15
Drug-induced rhabdomyolysis (DIR) is an idiosyncratic and fatal adverse drug reaction (ADR) characterized in severe muscle injuries accompanied by... 
SLCO1B1 | RISK-FACTORS | CONCOMITANT USE | PHARMACOLOGY & PHARMACY | CERIVASTATIN | STATIN-INDUCED MYOPATHY | SIMVASTATIN | Drugs | Complications and side effects | Usage | Rhabdomyolysis | Analysis
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2005, Volume 46, Issue 8, pp. 1411 - 1416
Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy Stephen D. Wiviott,... 
MORTALITY | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | SERUM-CHOLESTEROL | MEN | RISK | ACUTE CORONARY SYNDROMES | PRAVASTATIN | CERIVASTATIN | ATORVASTATIN | Evaluation | Coronary heart disease | Cardiac patients | Low density lipoproteins | Cardiovascular agents | Liver | Antilipemic agents
Journal Article
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 04/2018, Volume 46, Issue 4, p. 405
Hepatocyte drug depletion-time assays are well established for determination of metabolic clearance in vitro. The present study focuses on the refinement and... 
Cytochrome | Clarithromycin | Centrifugation | Cytochrome P450 | Liver | Tolbutamide | Clearances | Rifamycin | Erythromycin | Metabolism | Assaying | Rifamycins | Cerivastatin | Saquinavir | Depletion | Inhibitors | Hepatocytes | Atorvastatin | Midazolam | Intracellular | Protein transport | Transporter | Indinavir
Journal Article
Journal Article
International Journal of Epidemiology, ISSN 0300-5771, 12/2017, Volume 46, Issue 6, pp. 2078 - 2089
Journal Article
Journal of Applied Toxicology, ISSN 0260-437X, 08/2019, Volume 39, Issue 8, pp. 1224 - 1232
Journal Article
by Espano, E and Nam, JH and Song, EJ and Song, D and Lee, CK and Kim, JK
SCIENTIFIC REPORTS, ISSN 2045-2322, 08/2019, Volume 9, Issue 1, pp. 11461 - 11
Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family. ZIKV infection has been associated with neurological complications such as... 
DENGUE | DRUG | ENTRY | MULTIDISCIPLINARY SCIENCES | INFECTION | SIMVASTATIN | LIPIDS | Neonates | Antiviral agents | Guillain-Barre syndrome | Simvastatin | Lovastatin | Infections | Zika virus | Cerivastatin | Cholesterol | Lipophilic | Fluvastatin | Microencephaly | Neurological complications | Atorvastatin | Cardiovascular diseases | Statins | Vero cells | Compactin
Journal Article